Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | GMNN | O75496 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | THPO | P40225 | 1/20 | 0.54 |
| ▸ | MTOR | P42345 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CETP | P11597 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | UBE2N | P61088 | 1/20 | 0.54 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | FDPS | P14324 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL139953 | 0.97 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL136612 | 0.97 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL27963355 | 0.97 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL3344513 | 0.97 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL7756046 | 0.97 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL10607850 | 0.97 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL10605211 | 0.97 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL13825654 | 0.97 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL2385582 | 0.97 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB | |
| SCHEMBL10606337 | 0.97 | SPHK1 (0.62) | SPHK1CYP2D6LMNAGMNNPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1311 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3576847-B1 | SUNSCREEN COMPOSITIONS WITH NATURAL WAXES FOR IMPROVED WATER RESISTANCE | EDGEWELL PERSONAL CARE BRANDS LLC (US) | 2024-07-03 | — | — | EP | claimed |
| EP-2714004-B1 | CONTROLLED RELEASE PEPTIDE FORMULATIONS | CAMURUS AB (SE) | 2024-05-15 | — | — | EP | claimed |
| EP-3917503-B1 | METHODS OF PREPARING LIPID NANOPARTICLES | MODERNATX INC (US) | 2024-05-08 | — | — | EP | claimed |
| EP-3258789-B1 | OIL BLENDS AND THEIR USE IN COMPOSITIONS | FRUTAROM LTD (IL) | 2024-05-01 | — | — | EP | claimed |
| EP-4082530-B1 | PROTEASE INHIBITOR-CONTAINING COMPOSITIONS, COMPOSITIONS COMPRISING SAME, AND METHODS FOR PRODUCING AND USING SAME | ORAMED LTD (IL) | 2024-04-10 | — | — | EP | claimed |
| EP-3884783-B1 | OIL AND FAT COMPOSITION | KAO CORP (JP) | 2024-04-03 | — | — | EP | claimed |
| EP-3879992-B1 | LIQUID CREAMER AND METHOD FOR ITS PRODUCTION | NESTLE SA (CH) | 2024-02-28 | — | — | EP | claimed |
| EP-3879990-B1 | LIQUID CREAMER | NESTLE SA (CH) | 2024-02-28 | — | — | EP | claimed |
| US-20240002430-A1 | METHOD FOR PRODUCING PROTEIN COMPOSITIONS | HOFFMAN-LA ROCHE INC. (US) | 2024-01-04 | — | — | US | claimed |
| EP-3802762-B1 | PROCESS FOR THE PRODUCTION OF DIGLYCERIDES | DSM IP ASSETS BV (NL) | 2023-12-13 | — | — | EP | claimed |
| EP-0532915-A2 | Phosphoinositolglycan-peptide with insulin like activity | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-03-24 | — | — | EP | claimed |
| EP-0531684-A1 | Detergent composition | KAO CORPORATION (JP) | 1993-03-17 | — | — | EP | claimed |
| EP-0295092-B1 | SKIN TREATMENT COMPOSITION | UNILEVER PLC (GB) | 1992-09-23 | — | — | EP | claimed |
| EP-0335554-B1 | COSMETIC COMPOSITION | UNILEVER PLC (GB) | 1992-07-08 | — | — | EP | claimed |
| US-5080889-A | Oil, oxidation resistance, stability | KAO CORPORATION (JP) | 1992-01-14 | — | — | US | claimed |
| EP-0391431-A1 | Diacylglycerin and cosmetic composition | KAO CORPORATION (JP) | 1990-10-10 | — | — | EP | claimed |
| EP-0388778-A2 | Preparation of dioxolane derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1990-09-26 | — | — | EP | claimed |
| WO-1990009981-A1 | PREPARATION OF OPTICALLY ACTIVE GLYCEROL DERIVATIVES | ISIS INNOVATION LIMITED (GB) | 1990-09-07 | — | — | WO | claimed |
| EP-0319126-A2 | Process for preparation of polyol fatty acid ester and glyceride mixture obtained | Kao Corporation (JP) | 1989-06-07 | — | — | EP | claimed |
| US-4178299-A | Process for preparing 1,3-diacyl glycerols | ABBOTT LABORATORIES (US) | 1979-12-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002430-A1 | METHOD FOR PRODUCING PROTEIN COMPOSITIONS | CETP, IDE, LIPA | SPHK1 2503/4885CYP2D6 2617/4885LMNA 2770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.